Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
5.02
-0.47 (-8.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
Traws Pharma Revenue
Traws Pharma had revenue of $57.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $226.00K. In the year 2023, Traws Pharma had annual revenue of $226.00K.
Revenue (ttm)
$226.00K
Revenue Growth
n/a
P/S Ratio
22.06
Revenue / Employee
$12,556
Employees
18
Market Cap
15.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 226.00K | - | - |
| Dec 31, 2022 | 226.00K | - | - |
| Dec 31, 2021 | 226.00K | -5.00K | -2.16% |
| Dec 31, 2020 | 231.00K | -1.95M | -89.42% |
| Dec 31, 2019 | 2.18M | 955.00K | 77.77% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ImmunoPrecise Antibodies | 17.27M |
| Nephros | 13.55M |
| bioAffinity Technologies | 9.37M |
| Spruce Biosciences | 7.10M |
| Synlogic | 2.78M |
| Palatin Technologies | 2.38M |
| BioXcel Therapeutics | 2.28M |
TRAW News
- 5 weeks ago - Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results - GlobeNewsWire
- 2 months ago - Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - GlobeNewsWire
- 2 months ago - Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor - GlobeNewsWire
- 3 months ago - Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors - GlobeNewsWire
- 3 months ago - Traws Pharma, Inc. Announces Special Shareholders Meeting Results - GlobeNewsWire
- 4 months ago - Traws Pharma, Inc. (TRAW) Corporate Update Call Transcript - Seeking Alpha
- 4 months ago - Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights - GlobeNewsWire
- 4 months ago - Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET - GlobeNewsWire